Southwest Health Extension Partnership to Enhance Research Dissemination
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Detaillierte Beschreibung
Studientyp
Studientyp
Einschreibung (Tatsächlich)
Einschreibung
Phase
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Colorado
-
Denver, Colorado, Vereinigte Staaten
- University of Colorado, Denver
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Must be staff or clinicians (including physicians, nurse practitioners, and physician assistants) in an enrolled primary care practice
- Primary care practices must be family medicine or general internal medicine practices with a maximum of ten lead clinicians
- Primary care practices must be either independent or, if part of a larger organization, demonstrate on careful screening that they do not receive significant quality improvement support from the larger organization
Exclusion Criteria:
- Primary care practices with more than 10 lead clinicians
- Non-independent primary care practices that receive significant quality improvement support from their system or organization
- Clinicians and staff who do not speak or read English
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Versorgungsforschung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Anzahl der Arme
Waffen und Interventionen
Teilnehmergruppe / ArmTeilnehmergruppe / Arm |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Aktiver Komparator: Standard practice transformation support
Primary care practices will receive a cardiovascular care toolkit, practice facilitation, practice assessment with feedback, health information technology assistance, academic detailing, and periodic collaborative learning sessions
|
|
|
Experimental: Enhanced practice transformation support
Primary care practices will receive practice facilitation, practice assessment with feedback, health information technology assistance, academic detailing, and periodic collaborative learning sessions PLUS patient advisory council support and a modified cardiovascular care toolkit based on combined practice and patient input regarding the local context.
|
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change of documentation of aspirin therapy in patients with ischemic vascular disease.
Zeitfenster: Baseline, 3, 6, 9, 12, and 15 months from baseline
|
The percent of patients aged 18 years and older with Ischemic Vascular Disease (IVD) with documented use of aspirin or other antithrombotic.
This is a practice-level indicator of documentation of care processes for cardiovascular disease.
|
Baseline, 3, 6, 9, 12, and 15 months from baseline
|
|
Change of documentation of blood pressure in patients with a diagnosis of hypertension.
Zeitfenster: Baseline, 3, 6, 9, 12, and 15 months from baseline
|
The percent of patients aged 18 - 85 who had a diagnosis of hypertension (HTN) and whose blood pressure (BP) was adequately controlled (<140/90) during the measurement year.
This is a practice-level indicator of documentation of care processes for cardiovascular disease.
|
Baseline, 3, 6, 9, 12, and 15 months from baseline
|
|
Change of documentation of blood pressure in patients with adequately controlled blood pressure.
Zeitfenster: Baseline, 3, 6, 9, 12, and 15 months from baseline
|
The percent of patients aged 18 - 85 who had a diagnosis of hypertension (HTN) and whose blood pressure (BP) was adequately controlled (age 18-59 and/or people with diabetes or chronic kidney disease <140/90; age 60-85 <150/90) during the measurement year.
This is a practice-level indicator of documentation of care processes for cardiovascular disease.
|
Baseline, 3, 6, 9, 12, and 15 months from baseline
|
|
Change of documentation of fasting LDL in patients with a fasting LDL at or below the LDL goal.
Zeitfenster: Baseline, 3, 6, 9, 12, and 15 months from baseline
|
The percent of patients aged 20 - 79 who had a fasting LDL test performed and whose risk-stratified fasting LDL is at or below the recommended LDL goal.
This is a practice-level indicator of documentation of care processes for cardiovascular disease.
|
Baseline, 3, 6, 9, 12, and 15 months from baseline
|
|
Change of documentation of patients who had a fasting LDL test performed and prescribed a statin based on risk.
Zeitfenster: Baseline, 3, 6, 9, 12, and 15 months from baseline
|
The percent of patients aged 20 - 79 who had a fasting LDL test performed and who are prescribed a recommended dose of statin based on risk status if indicated.
This is a practice-level indicator of documentation of care processes for cardiovascular disease.
|
Baseline, 3, 6, 9, 12, and 15 months from baseline
|
|
Change of documentation of patients screened about tobacco use.
Zeitfenster: Baseline, 3, 6, 9, 12, and 15 months from baseline
|
The percent of patients aged 18 years or older screened about tobacco use one or more times within 24 months AND who received cessation counseling intervention if identified as a tobacco user.
This is a practice-level indicator of documentation of care processes for cardiovascular disease.
|
Baseline, 3, 6, 9, 12, and 15 months from baseline
|
Sekundäre Ergebnismessungen
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change of the documentation in primary care practice's.
Zeitfenster: Baseline, 9 and 15 months from baseline
|
This primary care practice capacity to implement PCOR findings and improve quality and implementation of the planned comprehensive approach.
The measure is based on practice-level scores of change process capacity, adaptive reserve, clinician experience and implementation of patient-centered medical home components.
|
Baseline, 9 and 15 months from baseline
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Mitarbeiter
Mitarbeiter
Ermittler
Ermittler
- Hauptermittler: W. Perry Dickinson, MD, University of Colorado, Denver
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Fernald DH, Mullen R, Hall T, Bienstock A, Kirchner S, Knierim K, de la Cerda D, Callan D, Rhyne RL, Dickinson LM, Dickinson WP. Exemplary Practices in Cardiovascular Care: Results on Clinical Quality Measures from the EvidenceNOW Southwest Cooperative. J Gen Intern Med. 2020 Nov;35(11):3197-3204. doi: 10.1007/s11606-020-06094-5. Epub 2020 Aug 17.
- English AF, Dickinson LM, Zittleman L, Nease DE Jr, Herrick A, Westfall JM, Simpson MJ, Fernald DH, Rhyne RL, Dickinson WP. A Community Engagement Method to Design Patient Engagement Materials for Cardiovascular Health. Ann Fam Med. 2018 Apr;16(Suppl 1):S58-S64. doi: 10.1370/afm.2173.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Studienbeginn
Primärer Abschluss (Tatsächlich)
Primärer Abschluss
Studienabschluss (Tatsächlich)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- 15-0403
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .